Simplified and highly sensitive serological testing for COVID-19 in rural regions of Sweden
- Funded by Vinnova
- Total publications:1 publications
Grant number: 2020-03103
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$110,000Funder
VinnovaPrincipal Investigator
N/A
Research Location
SwedenLead Research Institution
Aktiebolaget Grundstenen (under ändring till Xerum AB)Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Purpose and goal ** Denna text är maskinöversatt ** To verify feasibility and commercialization opportunity to perform large-scale and high-quality serological testing for COVID-19 via capillary blood sampling without significantly burdening the clinical laboratory at Region Västerbotten. Expected results and effects Results from this study will lay the foundation for large-scale serological testing and for further development of capillary blood sampling and diagnostics within infectious disease control and rural medicine. Planned approach and implementation Serological testing of the general public will commence shortly at Region Västerbotten. Xerum AB will facilitate sending out and receiving dried blood spot cassettes for capillary blood sampling, as well as quality control and reagents for sensitive analysis of samples. Test results are analyzed and sent out by Region Västerbotten. As a final step, the process will be evaluated by the three project participants for further development of the process and potential continuation.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC